These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7882598)

  • 1. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure.
    Yamada K; Miyahara Y; Hamaguchi K; Nakayama M; Nakano H; Nozaki O; Miura Y; Suzuki S; Tuchida H; Mimura N
    Clin Nephrol; 1994 Dec; 42(6):354-61. PubMed ID: 7882598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney transplantation decreases the tissue level of advanced glycosylation end-products.
    Lee WK; Akyol M; Shaw S; Dominiczak MH; Briggs JD
    Nephrol Dial Transplant; 1995; 10(1):103-7. PubMed ID: 7724002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation.
    Yoshida S; Yamada K; Hamaguchi K; Nishimura M; Hatakeyama E; Tsuchida H; Sakamoto K; Kashiwabara H; Yokoyama T; Ikeda K; Horiuchi S
    Clin Nephrol; 1998 May; 49(5):273-80. PubMed ID: 9617488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous ambulatory peritoneal dialysis (CAPD) in patients with diabetic nephropathy.
    Kemperman FA; van Leusen R; van Liebergen FJ; Oosting J; Boeschoten EW; Struijk DG; Krediet RT; Arisz L
    Neth J Med; 1991 Jun; 38(5-6):236-45. PubMed ID: 1922596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival on peritoneal dialysis in end-stage renal disease owing to diabetes.
    Passadakis P; Thodis E; Vargemezis V; Oreopoulos D
    Adv Perit Dial; 2000; 16():59-66. PubMed ID: 11045263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients.
    Nakamura S; Tachikawa T; Tobita K; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Weigle B; Pischetsrieder M; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S61-7. PubMed ID: 12612955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ; Struijk DG; de Blok K; Krediet RT
    Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continuous ambulatory peritoneal dialysis: is long-term therapy possible?].
    Olszowska A; Antosiewicz S; Pietrzak B
    Pol Merkur Lekarski; 2000 Dec; 9(54):845-8. PubMed ID: 11255652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycosylated end-products (AGEs) in non-diabetic patients undergoing dialysis.
    Brunkhorst R; Kruse M; Ehlerding G; Mahiout A
    Clin Nephrol; 1996 Oct; 46(4):265-6. PubMed ID: 8905214
    [No Abstract]   [Full Text] [Related]  

  • 11. [Program of continuous ambulatory peritoneal dialysis and renal transplantation in insulin-dependent diabetics in the terminal stage of renal insufficiency].
    Mousson C; Tanter Y; Chalopin JM; Rifle G
    Nephrologie; 1987; 8(4):205-9. PubMed ID: 3320798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation endproducts (AGEs) as uremic toxins.
    Schwenger V; Zeier M; Henle T; Ritz E
    Nahrung; 2001 Jun; 45(3):172-6. PubMed ID: 11455783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term continuous ambulatory peritoneal dialysis in diabetics.
    Balaskas EV; Yuan ZY; Gupta A; Meema HE; Blair G; Bargman J; Oreopoulos DG
    Clin Nephrol; 1994 Jul; 42(1):54-62. PubMed ID: 7923968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of continuous ambulatory peritoneal dialysis and kidney transplantation on advanced glycation endproducts in the skin and peritoneum.
    Shaw S; Akyol M; Bell J; Briggs JD; Dominiczak MH
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1061-8. PubMed ID: 9846888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment by continuous ambulatory peritoneal dialysis for chronic renal insufficiency in the diabetic].
    Rottembourg J; Issad B; Allouache M; Diab R; Hamani A; Jacobs C
    Nephrologie; 1995; 16(1):111-21. PubMed ID: 7700411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
    Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
    Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of renal function in patients treated by CAPD.
    Rottembourg J; Issad B; Allouache M; Jacobs C
    Adv Perit Dial; 1989; 5():63-6. PubMed ID: 2577429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic renal insufficiency in the diabetic by dialysis and transplantation].
    Legrain M; Rottembourg J; Jacobs C
    Diabete Metab; 1985 Feb; 11(1):51-69. PubMed ID: 3884405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.